Van Hauwermeiren Timothy
SEC CIK 1816206 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DNLI | Denali Therapeutics Inc. | Dir | 17.0K | — | — | 2 | 2025-11-04 | 2026-06-03 |
Most active insiders at DNLI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watts Ryan J. | Pres, CEO, Dir | — | $580.8K |
| 2 | Schuth Alexander O. | COFO, Sec | — | $420.6K |
| 3 | Thornberry Nancy | Dir | — | $261.9K |
| 4 | Chin Peter Scott | Chief Medical Off | — | $36.9K |
| 5 | Van Hauwermeiren Timothy | Dir | — | — |
| 6 | Cook Jennifer E. | Dir | — | — |
| 7 | Krognes Steve E. | Dir | — | — |
| 8 | Schenkein David P | Dir | — | — |
| 9 | Klein Peter S | Dir | — | — |
| 10 | BAKER BROS. ADVISORS LP | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-05 16:44 | 2026-06-03 | DNLI | Denali Therapeutics Inc. | Van Hauwermeiren Timothy | Dir | A - Grant | $0.00 | +6,408 | 17.0K | +60% | $0 |
| D | 2025-11-06 | 2025-11-04 | DNLI | Denali Therapeutics Inc. | Van Hauwermeiren Timothy | Dir | A - Grant | $0.00 | +10.6K | 10.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations